GEN-MKT-18-7897-A
Aug 27, 2019 | Blogs, Food / Beverage | 0 comments
Now that cannabis is legalized in a majority of the United States and Canada, new regulations to help protect consumers lead us to an important question: What are they getting? Here, we’ll help provide the answer.
Image source: Shayanne Gal/Business Insider
Some of the main goals behind cannabis regulation are to ensure that consumers know what’s in their cannabis and that the products aren’t contaminated with things like harmful pesticides. One evaluation of the most readily available CBD products in the US (from online retailers) showed only 31% were accurately labeled for CBD concentration. The study highlighted the need for manufacturing and testing standards and general oversight of cannabis products.
State testing regulations for pesticides in cannabis products are inconsistent. For example, California implemented mandatory testing shortly after legalization in early 2018, but Washington has prohibited the use of certain pesticides and doesn’t require any testing. There are all sorts of reasons why cannabis can become contaminated with pesticides, but the only way to know for sure is to test. In California, 3,373 batches of cannabis products failed safety testing between July 1 and November 30, 2018. Of those failures, 700 rejections were because of pesticides.
While the enforcement of mandatory pesticide testing remains a challenge for some, there are also analytical challenges that cannabis testing labs need to overcome.
Cannabis Analysis That’s Up to the ChallengeWhen it comes to making your lab operations more efficient and productive, you need a high-performance instrument that’s tough enough to handle routine cannabis testing and to meet the needs of ongoing regulatory changes. You need an LC-MS/MS solution that can stand up to these common testing challenges:
SCIEX offers world-class solutions designed to simplify your workflows and get you operational as quickly as possible. Explore the incredibly sensitive SCIEX Triple Quad™ 6500+ or QTRAP® 6500+ system featuring advanced SCIEX technology, combined with our vMethod™ and our expert application support and training.
Download the Top 5 Pesticides Challenges in Cannabis to find out how SCIEX can make your laboratory operations easier and more productive.
It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Here is an overview of just some of the ways SCIEX is working to support these challenges.
In a recent webinar, available on demand, scientists Luiza Chrojan and Ryan Hylands from Pharmaron, provided insights into the deployment of capillary gel electrophoresis (CGE) within cell and gene therapy. Luiza and Ryan shared purity data on plasmids used for adeno-associated virus (AAV) manufacturing and data on AAV genome integrity, viral protein (VP) purity and VP ratios using the BioPhase 8800 system.
Last year, Technology Networks hosted two webinars that featured groundbreaking research utilizing SWATH DIA (data-independent acquisition) for exposomics and metabolomics. Researchers Dr. Vinicius Verri Hernandes from the University of Vienna and Dr. Cristina Balcells from Imperial College London (ICL) demonstrated how a DIA approach can be successfully implemented in small molecule analysis using the ZenoTOF 7600 system. Their innovative approaches highlight the potential of SWATH DIA to enhance the detection and analysis of chemical exposures and metabolites, paving the way for new insights into environmental health and disease mechanisms.
Posted by
You must be logged in to post a comment.
Share this post with your network